Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

PREFer Recruiting

2024-520138-31-00 Early-stage favorable classic Hodgkin lymphoma 4 2026-06-01
A Phase 2 Study of JNJ-79635322 in Participants with RRMM Recruiting

2025-521976-80-00 Relapsed or Refractory Multiple Myeloma (RRMM) 4 2026-05-28
Phase 1b Study of Tarlatamab + ZL-1310 +/- Anti-PD-L1 in Small Cell Lung Cancer Recruiting

2025-522888-15-00 Small Cell Lung Cancer 3 2026-05-27
A Phase 3 Study Comparing JNJ-79635322 and an anti-BCMAxCD3 Bispecific Antibody in Participants with Relapsed or Refractory Multiple Myeloma Recruiting

2025-522007-18-00 Relapsed or Refractory Multiple Myeloma 5 2026-05-27
Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial Recruiting

2025-522128-28-00 Breast cancer 3 2026-05-26
Study of GVV858 as a single agent or in combination with endocrine therapy in patients with HR+/HER2- breast cancer and other advanced solid… Recruiting

2025-521911-38-00 Advanced HR+/HER- breast cancer 7 2026-05-26
MAVRiC studies 2L treatment with AV in patients with CLL/SLL who have relapsed after a course of BTKi + BCL2i combination, with and without … Recruiting

2024-518858-17-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 4 2026-05-22
A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours) Recruiting

2025-522913-45-00 Advanced relapsed or refractory ovarian cancer 3 2026-05-21
A clinical trial of ifinatamab deruxtecan in people with advanced esophageal cancer (MK-3475-06F) Recruiting

2026-525213-31-00 Esophageal squamous cell carcinoma 4 2026-05-21
Study to assess the efficacy and safety of Rina-S in participants with non-small cell lung cancer Recruiting

2025-522107-18-00 Locally advanced or metastatic Non-Small Cell Lung Canc 4 2026-05-19
CA-4948-203: A Ph2 Study of Emavusertib + an Approved BTKi in Patients with CLL and Other B-cell Malignancies Recruiting

2025-523600-68-00 Chronic Lymphocytic Leukemia and Other B-cell Malignanc 4 2026-05-19
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants with Platinum-Resistant (Part A) and Platinum-Sensitive (Part B… Recruiting

2025-522255-25-00 Fallopian Tube Neoplasms 5 2026-05-18
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors Recruiting

2024-519862-33-01 Advanced renal cell carcinoma (RCC) 1 2026-05-18
A Global Study Testing the New Drug Olverembatinib combined with chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Pos… Recruiting

2024-511496-14-00 Newly Diagnosed Philadelphia Chromosome-Positive Acute 5 2026-05-14
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043) Recruiting

2025-524160-38-00 Renal Cell Carcinoma, hepatocellular carcinoma, nonMSI- 5 2026-05-12
The combination of Elacestrant and exemestane for patients with pretreated metastatic breast cancer expressing hormone receptors and non-exp… Recruiting

2024-519792-25-00 Metastatic hormone receptor-positive/HER2-negative brea 4 2026-05-11
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Pretreated Unresectable Locally Advanced or Metastatic 10 2026-05-08
Phase 3 study comparing ivonescimab alone or ivonescimab with ligufalimab versus pembrolizumab for the first-line treatment of recurrent and… Recruiting

2025-522996-27-00 recurrent and/or metastatic squamous cell carcinoma of 5 2026-05-05
A clinical study of sacituzumab tirumotecan in people with ovarian cancer (MK-2870-021) Recruiting

2023-508047-40-00 Ovarian cancer 5 2026-04-30
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB 3111) Compared With Venetoclax Plus Acalabrutinib in Patients With Pre… Recruiting

2025-524366-21-00 treatment-naive Chronic Lymphocytic Leukemia 5 2026-04-29
A Study of YL201 in Combination with Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors Recruiting

2025-523742-27-00 Advanced solid tumors 9 2026-04-28
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing adjuvant Elacestrant with standard endocrine treatment in genomically and/… Recruiting

2025-522484-15-00 ER+/HER2- early breast cancer 5 2026-04-27
L19IL2 or L19TNF or L19IL2/TNF in patients with basal cell carcinoma (BCC) Recruiting

2025-523229-16-00 locally advanced basal cell carcinoma patients 4 2026-04-27
L19IL2/TNF in patients with basal cell carcinoma Recruiting

2025-523230-77-00 Patients with locally advanced Basal Cell Carcinoma (La 4 2026-04-27